O’Melveny’s Geng Cited in The Asian Lawyer on Chinese Take Private Transactions

June 30, 2015

The Asian Lawyer’s June 22, 2015, article, “Lawyers Double Dip as Chinese Clients ‘Go Private,’” details the trend of Chinese companies delisting from US stock exchanges and returning to their home country.  The article notes O’Melveny & Myers’ representation of Wuxi PharmaTech in its proposed US$3.3 billion deal to delist from the New York Stock Exchange.

Partner Ke Geng spoke with the publication about how some of these companies choose to remain in the United States.  Geng noted that some companies may earn better valuations on the Nasdaq or NYSE than they would in China, while others may not get the shareholder approval necessary to delist.

Geng is a member of O’Melveny’s Capital Markets Practice and resides in the Firm’s Beijing office.